Evolving molecular subtyping of breast cancer advances precision treatment

Rui Shan^#^{1

2}, Lei-Jie Dai^#^{1

2}, Zhi-Ming Shao^{1

2}, Yi-Zhou Jiang^{1

2}

Affiliations

¹ Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

^# Contributed equally.

Editorial

Rui Shan et al. Cancer Biol Med. 2024.

. 2024 Sep 19;21(9):731-739.

doi: 10.20892/j.issn.2095-3941.2024.0222.

Rui Shan^#^{1

2}, Lei-Jie Dai^#^{1

2}, Zhi-Ming Shao^{1

2}, Yi-Zhou Jiang^{1

2}

¹ Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

^# Contributed equally.

No abstract available

Conflict of interest statement

No potential conflicts of interest are disclosed.

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. - PubMed
1. Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134–50. - PubMed
1. Cleator S, Ashworth A. Molecular profiling of breast cancer: clinical implications. Br J Cancer. 2004;90:1120–4. - PMC - PubMed
1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52. - PubMed
1. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–74. - PMC - PubMed